120 related articles for article (PubMed ID: 17614156)
1. Multimodal treatment of thymic carcinoma: Report of nine cases.
Magois E; Guigay J; Blancard PS; Margery J; Milleron B; Lher P; Jounieaux V
Lung Cancer; 2008 Jan; 59(1):126-32. PubMed ID: 17614156
[TBL] [Abstract][Full Text] [Related]
2. A single institutional experience of surgically resected thymic epithelial tumors over 10 years: clinical outcomes and clinicopathologic features.
Kim BK; Cho BC; Choi HJ; Sohn JH; Park MS; Chang J; Kim SK; Kim DJ; Chung KY; Lee CG; Kim JH; Yoo NC
Oncol Rep; 2008 Jun; 19(6):1525-31. PubMed ID: 18497960
[TBL] [Abstract][Full Text] [Related]
3. Thymic carcinoma: a report of 13 cases.
Lucchi M; Mussi A; Ambrogi M; Gunfiotti A; Fontanini G; Basolo F; Angeletti CA
Eur J Surg Oncol; 2001 Nov; 27(7):636-40. PubMed ID: 11669591
[TBL] [Abstract][Full Text] [Related]
4. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial.
Loehrer PJ; Jiroutek M; Aisner S; Aisner J; Green M; Thomas CR; Livingston R; Johnson DH
Cancer; 2001 Jun; 91(11):2010-5. PubMed ID: 11391579
[TBL] [Abstract][Full Text] [Related]
5. Advanced stage thymomas and thymic carcinomas: results of multimodality treatments.
Lucchi M; Ambrogi MC; Duranti L; Basolo F; Fontanini G; Angeletti CA; Mussi A
Ann Thorac Surg; 2005 Jun; 79(6):1840-4. PubMed ID: 15919267
[TBL] [Abstract][Full Text] [Related]
6. Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group.
Hartmann JT; Gauler T; Metzner B; Gerl A; Casper J; Rick O; Horger M; Schleicher J; Derigs G; Mayer-Steinacker R; Beyer J; Kuczyk MA; Bokemeyer C;
J Clin Oncol; 2007 Dec; 25(36):5742-7. PubMed ID: 18089869
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma.
Kim DW; Jo YH; Kim JH; Wu HG; Rhee CS; Lee CH; Kim TY; Heo DS; Bang YJ; Kim NK
Cancer; 2004 Nov; 101(10):2257-60. PubMed ID: 15484215
[TBL] [Abstract][Full Text] [Related]
8. Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection.
D'Angelillo RM; Trodella L; Ramella S; Cellini N; Balducci M; Mantini G; Cellini F; Ciresa M; Fiore M; Evoli A; Sterzi S; Russo P; Grozio A; Cesario A; Granone P
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):420-7. PubMed ID: 18164843
[TBL] [Abstract][Full Text] [Related]
9. Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis.
Ströbel P; Bauer A; Puppe B; Kraushaar T; Krein A; Toyka K; Gold R; Semik M; Kiefer R; Nix W; Schalke B; Müller-Hermelink HK; Marx A
J Clin Oncol; 2004 Apr; 22(8):1501-9. PubMed ID: 15084623
[TBL] [Abstract][Full Text] [Related]
10. Treatment of pediatric malignant thymoma: long-term remission in a 14-year-old boy with EBV-associated thymic carcinoma by aggressive, combined modality treatment.
Niehues T; Harms D; Jürgens H; Göbel U
Med Pediatr Oncol; 1996 Jun; 26(6):419-24. PubMed ID: 8614381
[TBL] [Abstract][Full Text] [Related]
11. Treatment of base of tongue cancer with paclitaxel, ifosfamide, and cisplatinum induction chemotherapy followed by chemoradiotherapy.
Hancock SB; Krempl GA; Canfield V; Bogardus C; Kojouri K; Kaneaster SK; Medina JE
Laryngoscope; 2008 Aug; 118(8):1357-61. PubMed ID: 18528311
[TBL] [Abstract][Full Text] [Related]
12. Multimodality therapy for patients with invasive thymoma disseminated into the pleural cavity: the potential role of extrapleural pneumonectomy.
Ishikawa Y; Matsuguma H; Nakahara R; Suzuki H; Ui A; Kondo T; Kamiyama Y; Igarashi S; Mori K; Kodama T; Yokoi K
Ann Thorac Surg; 2009 Sep; 88(3):952-7. PubMed ID: 19699926
[TBL] [Abstract][Full Text] [Related]
13. Interdisciplinary combined treatment of craniofacial osteosarcoma with neoadjuvant and adjuvant chemotherapy and excision of the tumour: a retrospective study.
Thiele OC; Freier K; Bacon C; Egerer G; Hofele CM
Br J Oral Maxillofac Surg; 2008 Oct; 46(7):533-6. PubMed ID: 18436357
[TBL] [Abstract][Full Text] [Related]
14. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
[TBL] [Abstract][Full Text] [Related]
15. Preliminary report of multimodal treatment with ifosfamide, 5-fluorouracil, etoposide and cisplatin (IFEP chemotherapy) against metastatic adenocarcinoma of the urachus.
Tatokoro M; Kawakami S; Yonese J; Fujii Y; Okubo Y; Yamamoto S; Takeshita H; Komai Y; Ishikawa Y; Fukui I
Int J Urol; 2008 Sep; 15(9):851-3. PubMed ID: 18786207
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: a Spanish Germ Cell Cancer Group Study.
Garcia-del-Muro X; Maroto P; Gumà J; Sastre J; López Brea M; Arranz JA; Lainez N; Soto de Prado D; Aparicio J; Piulats JM; Pérez X; Germá-Lluch JR
J Clin Oncol; 2008 Nov; 26(33):5416-21. PubMed ID: 18936476
[TBL] [Abstract][Full Text] [Related]
17. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H
Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848
[TBL] [Abstract][Full Text] [Related]
18. Sarcoma of the prostate: a single institutional review.
Janet NL; May AW; Akins RS
Am J Clin Oncol; 2009 Feb; 32(1):27-9. PubMed ID: 19194120
[TBL] [Abstract][Full Text] [Related]
19. [The diagnosis and treatment of the thymic carcinoma].
Moriyama H; Nishimura Y; Kuwabara K; Hishima T; Moriyama S
Gan To Kagaku Ryoho; 2003 May; 30(5):595-8. PubMed ID: 12795088
[TBL] [Abstract][Full Text] [Related]
20. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response.
Pourel N; Santelmo N; Naafa N; Serre A; Hilgers W; Mineur L; Molinari N; Reboul F
Eur J Cardiothorac Surg; 2008 May; 33(5):829-36. PubMed ID: 18367406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
